People on the Move
Genkyotex
Genkyotex, a maker of selective NOX enzyme inhibitors, has announced the hire of Jeanette Wood as Chief Scientific Officer (CSO) and the appointment of Joseph McCracken to the board of directors.
Wood has spent 30 years working in research in the pharmaceutical industry, most recently at AstraZeneca. There, she was VP and Head of iScience and Oncology iMed – a role with responsilbility for the cancer early discovery portfolio, mostly small molecule.
McCracken has more than 25 years of experience in technical, business development and market development roles within biopharmaceutical and pharmaceutical companies. His last job was Global Head of Business Development and Licensing at Roche Pharma, where he was responsible for global in-licensing and out-licensing.